Finance
The company, formerly named Thryve, also hired a new CEO and a chief product officer.
This new infusion of cash brings the company's total funding to $28 million.
The new technology is being developed for in-hospital and at-home use.
The funding will help clinicians manage elective recovery backlogs in the NHS.
According to reporting by TechCrunch, employee morale is low as the company struggles to expand successfully beyond its men’s health products.
Hinge said more than $1 billion has been invested in the company thus far.
At the beginning of October, Transcarent inked a deal with Walmart to lower prescription drugs.
Also: Anomaly scores $17 million for health payments, and Arine rakes in $11 million for medication management.
This new funding round brings the company's total raise to $521 million.
It has set up a new entity offering preventive healthcare solutions.